Insider Buy ·Filed Jun 9, 2026

EYE

National Vision Holdings, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SECEYE-1781038564537
Insider cluster: 1 insiders, $776K total
Actionable Insight • Neutral

The $776K director buy is too small relative to market cap to signal material conviction. Historical EYE reports have underperformed at T+20. Monitor for additional insider buying or a material catalyst before acting.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
EYE ▼ -4.04% at T+60d
NEUTRAL call ✗ call lost -4.04% · α vs SPY -10.62% · entry $17.58 → $16.87
Entry anchored
Jun 9, 03:59 PM ET
via exchange tick
T+1d
+3.81%
call +3.81% · α +2.11%
$18.25
settled 4mo ago
T+5d
-0.06%
call -0.06% · α -3.49%
$17.57
settled 4mo ago
T+20d
+11.09%
call +11.09% · α +7.47%
$19.53
settled 3mo ago
T+60d
-4.04%
call -4.04% · α -10.62%
$16.87
settled 29d ago

Price Chart

Loading chart...

Executive Summary

Director Michael J. Nicholson purchased $776K of EYE shares on the open market at $15.52, a single-insider conviction buy representing ~0.06% of market cap. The purchase is small relative to the $1.3B market cap and follows a period of poor historical T+20 performance for prior reports on this ticker.

Key Financial Metrics

Direction
buying
Total Value
$776.0K
Insiders
1

Key Facts

  • Director Michael J. Nicholson bought 50,000 shares at $15.52 for $776K on June 5, 2026.
  • Purchase represents ~0.06% of $1.3B market cap, below the 0.1% threshold for materiality.
  • Only one insider traded; no C-suite involvement.
  • Prior EYE reports had a 0% T+20 win rate with average alpha of -20.55% vs SPY.

Financial Impact

$776K open-market purchase, ~0.06% of market cap

insider ownership

Risk Factors

  • Single director buy lacks C-suite confirmation; may be personal portfolio adjustment.
  • Historical T+20 performance for EYE reports is negative, suggesting limited predictive value.
  • Purchase size is trivial relative to $1.3B market cap.

Market Snapshot

Exchange
Nasdaq
Sector
Ophthalmic Goods
Analyst Consensus
75% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)EYE-1781038564537
2 reports for EYE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EYE — sortable, filterable
TypeNow
Jun 16, 2026
15w ago
Institutional Cluster
BULLISH ★ 6/10
$17.57 $17.13▼ −2.50%▼ −3.50%$16.40 (−6.66%)
Jun 9, 2026
16w ago
Insider Buy
NEUTRAL ★ 3/10
$17.58 $16.87▼ −4.04%▼ −10.62%$16.40 (−6.71%)
Showing 2 of 2

US Market Status

Market Closed — Opens Mon (64h 18m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access